(Q44835478)

English

Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus

scientific article published in October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

type 2 diabetes

0 references

Giuseppe Derosa

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

A Mugellini

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

P Preti

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

A Zoppi

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

L Corradi

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

E Fogari

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

R Fogari

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Journal of Human Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

687-691

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

Antihypertensive drug treatment and fibrinolytic function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

Pharmacokinetic and pharmacologic properties of delapril, a lipophilic nonsulfhydryl angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

Manidipine: a review of its use in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

Evidence for a rapid inhibitor to tissue plasminogen activator in plasma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

Association of Blood Pressure With Fibrinolytic Potential in the Framingham Offspring Population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

21 January 2018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendations for special populations: diabetes mellitus and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased levels of tissue plasminogen activator antigen in essential hypertension. A population-based study in Sweden

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased fibrinolytic activity and increased platelet function in hypertension. Possible influence of calcium antagonism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin II receptor blockade on fibrinolysis during acute hyperinsulinemia in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasminogen activator release during venous stasis and exercise as determined by a new specific assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001726

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.JHH.1001726

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

release_ni3ddvhh4nc2vpos7qah2pweim

1 reference

https://api.fatcat.wiki/v0/release/ni3ddvhh4nc2vpos7qah2pweim

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44835478&oldid=2206951219"